Masayon, Joriana Ishiend .
HRN: 23-15-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
OXACILLIN 500MG (VIAL)
06/11/2023
06/17/2023
IV
275mg
Q6
T/C Impetigo With Superimposed Bacterial Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes